Radio Therapeutics Corporation


Public lists: Pharma Startups (4732)

Radio Therapeutics Corporation develops and manufactures radiofrequency-based therapeutic devices for the destruction of various forms of soft tissue tumors. RTC markets the Radiofrequency Ablation System, which uses radiofrequency energy to selectively destroy undesirable soft tissue. The technology is based on hyperthermia (overheating) of the tumor to destroy it with the use of a specially designed probe which is inserted into the tumor. The probe architecture is the core of the technology an...Show all

Radio Therapeutics Corporation develops and manufactures radiofrequency-based therapeutic devices for the destruction of various forms of soft tissue tumors. RTC markets the Radiofrequency Ablation System, which uses radiofrequency energy to selectiv...Show all

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Radio Therapeutics Corporation $0M Nov 30, 2018
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Radio Therapeutics Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

AVEO Oncology

Cambridge, Massachusetts, United States
IPO / Went publicAVEO Oncology, formerly AVEO Pharmaceuticals, has built inducible, tissue-specific in vivo cancer models with which to discover drugs. Each model contains signature genetic mutations, and natural genetic variation akin to the genetic heterogeneity encountered across different primary tumors. Further, tumors that arise in this model have a number of differing phenotypes, including significant variation in tissue architecture and angiogenic potential.Login to see details

Biofisica

Duluth, Georgia, United States
Alive / ActiveBiofisica develops and markets products for soft tissue wound healing and tissue regeneration based on an exclusive and technology that uses electrical stimulation and hydro-gel materials.Login to see details
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)